Registration Rights Agreements in the Pharmaceuticals Industry

634 Contracts & Agreements

Browse by Company

Acacia Diversified Holdings, Inc. (1 contract)
Accelerated Pharma, Inc. (1)
ACELRX PHARMACEUTICALS INC (2)
Acer Therapeutics Inc. (5)
Aclaris Therapeutics, Inc. (2)
Acreage Holdings, Inc. (1)
Adamis Pharmaceuticals Corp (7)
ADIAL PHARMACEUTICALS, INC. (4)
AEOLUS PHARMACEUTICALS, INC. (10)
AEON Biopharma, Inc. (1)
AERIE PHARMACEUTICALS INC (1)
Aerpio Pharmaceuticals, Inc. (4)
AGILE THERAPEUTICS INC (2)
Akers Biosciences, Inc. (2)
Akorn (2)
ALDER BIOPHARMACEUTICALS INC (2)
Alexza Pharmaceuticals Inc. (1)
ALIMERA SCIENCES INC (5)
Allergan, plc (1)
ALSERES PHARMACEUTICALS INC (1)
Altus Pharmaceuticals Inc. (1)
Amag Pharmaceuticals (1)
Amphastar Pharma (1)
Anacor Pharmaceuticals, Inc. (2)
Angion Biomedica Corp. (1)
ANI Pharma Inc (1)
Anthera Pharmaceuticals Inc (2)
APP Pharmaceuticals, Inc. (2)
Applied BioSciences Corp. (1)
APRICUS BIOSCIENCES, INC. (10)
Aquestive Therapeutics, Inc. (2)
ARADIGM CORP (4)
Aralez Pharmaceuticals Inc. (9)
ARIAD PHARMACEUTICALS INC (1)
ARTELO BIOSCIENCES, INC. (4)
ARVINAS, INC. (2)
Astex Pharmaceuticals, Inc (4)
AUXILIUM PHARMACEUTICALS INC (1)
AVADEL PHARMACEUTICALS PLC (2)
AVALON PHARMACEUTICALS INC (4)
AVENUE THERAPEUTICS, INC. (4)
AYTU BIOSCIENCE, INC (4)
Baudax Bio, Inc. (1)
Big Rock Partners Acquisition Corp. (7)
BIODELIVERY SCIENCES INTERNATIONAL INC (9)
Biofrontera Inc. (2)
BioNumerik Pharmaceuticals, Inc. (15)
BioPharmX Corp (5)
Blue Water Acquisition Corp. (5)
BODY & MIND INC. (1)
Bohai Pharmaceuticals Group, Inc. (1)
Boston Therapeutics, Inc. (3)
BRADLEY PHARMACEUTICALS INC (2)
Bright Green Corp (2)
Bristol-Myers Squibb (1)
Canbiola, Inc. (4)
Cannabics Pharmaceuticals Inc. (1)
CANNAPHARMARX, INC. (3)
CANNAPOWDER, INC. (1)
Canopy Growth Corp (1)
Cantabio Pharmaceuticals Inc. (1)
CARDAX, INC. (2)
Catalent Inc (3)
Celator Pharmaceuticals Inc (1)
Cerecor Inc. (6)
Cingulate Inc. (1)
Citius Pharmaceuticals, Inc. (2)
Clearside Biomedical, Inc. (1)
Clever Leaves Holdings Inc. (1)
CLS Holdings USA, Inc. (2)
CNS Pharmaceuticals, Inc. (2)
Cocrystal Pharma, Inc. (1)
COGNITION THERAPEUTICS INC (1)
Context Therapeutics Inc. (1)
ContraVir Pharmaceuticals, Inc. (1)
Corcept Therapeutics Incorporated (7)
CorMedix Inc. (5)
Cure Pharmaceutical Holding Corp. (1)
CymaBay Therapeutics, Inc. (1)
Dermata Therapeutics, Inc. (1)
DURECT CORP (1)
Egalet Corp (1)
Elanco Animal Health Inc (2)
ELITE PHARMACEUTICALS INC (4)
Eloxx Pharmaceuticals, Inc. (5)
ENCYSIVE PHARMACEUTICALS INC (2)
Endexx Corp (2)
Endo International plc (46)
EPIX Pharmaceuticals, Inc. (3)
Eton Pharmaceuticals, Inc. (1)
Evofem Biosciences, Inc. (10)
Evolus, Inc. (1)
Exactus, Inc. (3)
EYEGATE PHARMACEUTICALS INC (5)
EYENOVIA, INC. (1)
EyePoint Pharmaceuticals, Inc. (2)
Fulcrum Therapeutics, Inc. (1)
GENAISSANCE PHARMACEUTICALS INC (2)
GREEN HYGIENICS HOLDINGS INC. (3)
GridIron BioNutrients, Inc. (1)
HARROW HEALTH, INC. (2)
Haymaker Acquisition Corp. III (2)
Hoth Therapeutics, Inc. (5)
iANTHUS CAPITAL HOLDINGS, INC. (1)
Ikena Oncology, Inc. (1)
IMAGING3 INC (1)
INNOVATE BIOPHARMACEUTICALS, INC. (4)
Innoviva, Inc. (2)
IntelGenx Technologies Corp. (6)
Intersect ENT, Inc. (1)
Intra-Cellular Therapies, Inc. (1)
ISTA PHARMACEUTICALS INC (2)
Item 9 Labs Corp. (1)
Jaguar Health, Inc. (9)
Jazz Pharmaceuticals plc (1)
Jiangbo Pharmaceuticals, Inc. (2)
Johnson & Johnson (1)
JUNIPER PHARMACEUTICALS INC (2)
Kala Pharmaceuticals, Inc. (3)
Kedem Pharmaceuticals Inc. (1)
KEMPHARM, INC (4)
KING PHARMACEUTICALS INC (1)
KOLLTAN PHARMACEUTICALS INC (1)
KOS PHARMACEUTICALS INC (1)
Lev Pharmaceuticals Inc (1)
Level Brands, Inc. (1)
Lexaria Bioscience Corp. (1)
Lipocine Inc. (3)
Liquidia Corp (1)
Liquidia Technologies Inc (1)
Lyra Therapeutics, Inc. (2)
MAP Pharmaceuticals, Inc. (1)
Marijuana Co of America, Inc. (1)
MAXIM PHARMACEUTICALS INC (1)
MedGen, Inc. (1)
Menlo Therapeutics Inc. (2)
MICROCHANNEL TECHNOLOGIES CORP (3)
MiddleBrook Pharmaceuticals, Inc. (4)
Milestone Pharmaceuticals Inc. (1)
MIRA PHARMACEUTICALS, INC. (1)
MJ Holdings, Inc. (1)
Molecular Insight Pharmaceuticals, Inc. (2)
MYnd Analytics, Inc. (10)
Nabriva Therapeutics plc (1)
NEKTAR THERAPEUTICS (2)
Neos Therapeutics, Inc. (3)
Neuralstem, Inc. (5)
NEW RIVER PHARMACEUTICALS INC (1)
NewBridge Global Ventures, Inc. (2)
Notis Global, Inc. (6)
NovaBay Pharmaceuticals, Inc. (7)
Novan, Inc. (3)
NPS PHARMACEUTICALS INC (2)
NURX PHARMACEUTICALS, INC. (1)
OCULAR THERAPEUTIX, INC (2)
OMEROS CORP (1)
OncoMed Pharmaceuticals Inc (2)
Onconova Therapeutics, Inc. (1)
One World Pharma, Inc. (2)
OPIANT PHARMACEUTICALS, INC. (1)
OPTIMER PHARMACEUTICALS INC (1)
OptiNose, Inc. (3)
ORAMED PHARMACEUTICALS INC. (1)
OSCIENT PHARMACEUTICALS CORP (1)
OSI PHARMACEUTICALS INC (2)
Panacea Acquisition Corp (3)
PaxMedica, Inc. (1)
Perrigo (1)
Petros Pharmaceuticals, Inc. (2)
Pharmagreen Biotech Inc. (1)
PHARMOS CORP (5)
Phibro Animal Health Corporation (2)
PLAYERS NETWORK (3)
PLx Pharma Inc. (3)
PREDIX PHARMACEUTICALS HOLDINGS INC (1)
Prestige Brands Holdings Inc (2)
Processa Pharmaceuticals, Inc. (1)
ProPhase Labs, Inc. (2)
PROTECT PHARMACEUTICAL Corp (1)
PROVECTUS BIOPHARMACEUTICALS, INC. (3)
Provention Bio, Inc. (1)
QUANTA INC (2)
RADIENT PHARMACEUTICALS Corp (4)
Rani Therapeutics Holdings, Inc. (2)
REATA PHARMACEUTICALS INC (1)
Recro Pharma, Inc. (3)
Reliant Pharmaceuticals, Inc. (2)
RELMADA THERAPEUTICS, INC. (3)
RespireRx Pharmaceuticals Inc. (2)
resTORbio, Inc. (2)
Rib-X Pharmaceuticals, Inc. (1)
ROCK CREEK PHARMACEUTICALS, INC. (39)
Roivant Sciences Ltd. (1)
Royalty Pharma plc (5)
Satsuma Pharmaceuticals, Inc. (1)
SAVIENT PHARMACEUTICALS INC (1)
SCICLONE PHARMACEUTICALS INC (1)
Scopus BioPharma Inc. (2)
SCYNEXIS INC (1)
SenesTech, Inc. (1)
Sonoma Pharmaceuticals, Inc. (2)
Synovics Pharmaceuticals (1)
TAPESTRY PHARMACEUTICALS, INC (3)
Targeted Medical Pharma, Inc. (1)
TAURIGA SCIENCES, INC. (4)
Tenzing Acquisition Corp. (4)
Terra Tech Corp. (5)
TETRAPHASE PHARMACEUTICALS INC (1)
TEVA PHARMACEUTICAL INDUSTRIES LTD (4)
Textmunication Holdings, Inc. (2)
TFF Pharmaceuticals, Inc. (2)
TherapeuticsMD, Inc. (1)
Theravance Biopharma, Inc. (3)
TITAN PHARMACEUTICALS INC (7)
Tribute Pharmaceuticals Canada Inc. (3)
Trulieve Cannabis Corp. (1)
Urigen Pharmaceuticals, Inc. (6)
Urovant Sciences Ltd. (1)
VASO ACTIVE PHARMACEUTICALS INC (1)
Ventyx Biosciences, Inc. (1)
VIA Pharmaceuticals, Inc. (3)
Vitality Biopharma, Inc. (4)
Winston Pharmaceuticals, Inc. (1)
Xeris Biopharma Holdings, Inc. (1)
Zoetis (3)
Zynerba Pharmaceuticals, Inc. (1)

Recent Contracts

Registration Rights Agreement, dated September 21, 2023, by and between Oramed Pharmaceuticals Inc. and Scilex Holding Company (ORAMED PHARMACEUTICALS INC., Filed With SEC on September 26, 2023)
Form of Registration Rights Agreement, dated as of September 13, 2023, by and among the Company and The Sire Group Ltd (TITAN PHARMACEUTICALS INC, Filed With SEC on September 19, 2023)
Form of Registration Rights Agreement, dated as of September 13, 2023, by and among the Company and The Sire Group Ltd (TITAN PHARMACEUTICALS INC, Filed With SEC on September 18, 2023)
Form of Registration Rights Agreement (Canopy Growth Corp, Filed With SEC on September 18, 2023)
Registration Rights Letter Agreement, dated September 8, 2023, by and among the Company and the purchaser parties thereto (AVENUE THERAPEUTICS, INC., Filed With SEC on September 8, 2023)
Registration Rights Agreement dated as of August 30, 2023 by and among Zevra Therapeutics, Inc., and each of the sellers party thereto (KEMPHARM, INC, Filed With SEC on August 31, 2023)
Joinder and Amendment to Registration Rights Agreement dated as of May 17, 2023, by and among Alimera Sciences, Inc. and the purchasers party thereto (ALIMERA SCIENCES INC, Filed With SEC on August 11, 2023)
Form of Registration Rights Agreement (Evofem Biosciences, Inc., Filed With SEC on August 10, 2023)
Contingent Value Rights Agreement, dated August 4, 2023, by and between Ikena Oncology, Inc. and Computershare Trust Company N.A, as rights agent (Ikena Oncology, Inc., Filed With SEC on August 7, 2023)
Form of Registration Rights Agreement, dated July 17, 2023, by and between AcelRx Pharmaceuticals, Inc. and the Purchasers (ACELRX PHARMACEUTICALS INC, Filed With SEC on July 21, 2023)
Form of Registration Rights Agreement (Petros Pharmaceuticals, Inc., Filed With SEC on July 13, 2023)
Form of Registration Rights Agreement (Evofem Biosciences, Inc., Filed With SEC on July 10, 2023)
Registration Rights Agreement, dated June 23, 2023, between the Company and AJB Capital Investments LLC (One World Pharma, Inc., Filed With SEC on July 5, 2023)
Registration Rights Agreement, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Bay Shore Trust (MIRA PHARMACEUTICALS, INC., Filed With SEC on June 29, 2023)
Registration Rights Agreement, dated June 20, 2023 (Textmunication Holdings, Inc., Filed With SEC on June 23, 2023)
Registration Rights Agreement, dated as of May 25, 2023, by and among Lyra Therapeutics, Inc. and the Investors named therein (Lyra Therapeutics, Inc., Filed With SEC on May 31, 2023)
Registration Rights Agreement dated May 24, 2023, by and between the Company and the purchasers thereto (Bright Green Corp, Filed With SEC on May 24, 2023)
Registration Rights Agreement by and between the Company and AnnJi Pharmaceutical Co. Ltd., dated February 28, 2023 (AVENUE THERAPEUTICS, INC., Filed With SEC on May 12, 2023)
Registration Rights Agreement, dated as of May 3, 2023, by and between Johnson & Johnson and Kenvue Inc (Johnson & Johnson, Filed With SEC on May 8, 2023)
Form of Registration Rights Agreement (NovaBay Pharmaceuticals, Inc., Filed With SEC on April 27, 2023)
Registration Rights Agreement, dated April 24, 2023, by and between the Company and Lincoln Park Capital Fund, LLC (Cingulate Inc., Filed With SEC on April 25, 2023)
Walleye Registration Rights Agreement (Canbiola, Inc., Filed With SEC on April 17, 2023)
Form of Registration Rights Agreement (Evofem Biosciences, Inc., Filed With SEC on April 10, 2023)
Form of Registration Rights Agreement (Neuralstem, Inc., Filed With SEC on April 5, 2023)
Registration Rights Agreement between the Baudax Bio, Inc. and MAM Eagle Lender, LLC, dated March 29, 2023 (Baudax Bio, Inc., Filed With SEC on March 31, 2023)
Registration Rights Agreement, dated March 24, 2023, by and among Alimera Sciences, Inc. and the purchasers party thereto (ALIMERA SCIENCES INC, Filed With SEC on March 27, 2023)
Form of Registration Rights Agreement (Evofem Biosciences, Inc., Filed With SEC on March 24, 2023)
Form of Registration Rights Agreement (Evofem Biosciences, Inc., Filed With SEC on March 14, 2023)
Registration Rights Agreement, dated as of March 10, 2023, by and between Cognition Therapeutics, Inc. and Lincoln Park Capital Fund, LLC (COGNITION THERAPEUTICS INC, Filed With SEC on March 10, 2023)
Registration Rights Agreement, dated March 2, 2023, by and among the Registrant and the persons party thereto (Kala Pharmaceuticals, Inc., Filed With SEC on March 3, 2023)
Registration Rights Agreement, dated as of March 2, 2023, by and between the Company and Keystone Capital Partners, LLC (Level Brands, Inc., Filed With SEC on March 2, 2023)
Form of Registration Rights Agreement (Evofem Biosciences, Inc., Filed With SEC on February 23, 2023)
Registration Rights Agreement, dated as of February 3, 2023, by and between Kiora Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (EYEGATE PHARMACEUTICALS INC, Filed With SEC on February 3, 2023)
Registration Rights Agreement, dated as of February 2, 2023, by and between Kiora Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (EYEGATE PHARMACEUTICALS INC, Filed With SEC on February 3, 2023)
Form of Registration Rights Agreement, dated January 27, 2023, by and among the Company and the purchaser party thereto (AVENUE THERAPEUTICS, INC., Filed With SEC on February 1, 2023)
Form of Registration Rights Agreement (Neuralstem, Inc., Filed With SEC on January 4, 2023)
Form of Registration Rights Agreement (Hoth Therapeutics, Inc., Filed With SEC on December 30, 2022)
Registration Rights Agreement between Body and Mind Inc., BAM I, A Series of Bengal Catalyst Fund SPV, LP, Mindset Value Fund LP and Mindset Value Wellness Fund LP, dated December... (BODY & MIND INC., Filed With SEC on December 23, 2022)
Registration Rights Agreement, dated as of November 17, 2022, by and between the Company and Lincoln Park (PaxMedica, Inc., Filed With SEC on November 21, 2022)
Registration Rights Agreement, dated November 11, 2022, between VYNE Therapeutics Inc. and Mutual Fund Series Trust, on behalf of Alpha (Menlo Therapeutics Inc., Filed With SEC on November 14, 2022)